Ardent Capital Management’s AbbVie ABBV Stock Holding History

Ardent Capital Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$637K	Hold	2,530	–	–	0.26%	28
2026 Q1	$550K	Hold	2,530	–	–	0.24%	32
2025 Q4	$578K	Hold	2,530	–	–	0.23%	34
2025 Q3	$586K	Hold	2,530	–	–	0.25%	33
2025 Q2	$470K	Hold	2,530	–	–	0.23%	31
2025 Q1	$530K	Sell	2,530 -55	-2%	-$10.7K	0.23%	29
2024 Q4	$459K	Hold	2,585	–	–	0.21%	31
2024 Q3	$510K	Hold	2,585	–	–	0.23%	31
2024 Q2	$443K	Hold	2,585	–	–	0.22%	32
2024 Q1	$471K	Hold	2,585	–	–	0.24%	33
2023 Q4	$401K	Hold	2,585	–	–	0.21%	35
2023 Q3	$385K	Hold	2,585	–	–	0.22%	35
2023 Q2	$348K	Hold	2,585	–	–	0.21%	23
2023 Q1	$412K	Hold	2,585	–	–	0.3%	20
2022 Q4	$418K	Buy	+2,585	New	+$396K	0.32%	19
2022 Q3	–	Sell	-2,585	Closed	-$396K	–	15
2022 Q2	$396K	Hold	2,585	–	–	0.49%	14
2022 Q1	$419K	Hold	2,585	–	–	0.28%	21
2021 Q4	$350K	Buy	+2,585	New	+$305K	0.23%	25

Other funds holding ABBV

LMFP

Larry Mathis Financial Planning Phoenix, Arizona $124B AUM

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

HCM

Hamlin Capital Management New York $4.45B AUM 22.95% 1-Year Est. Return

AAMU

AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return

HPC

HM Payson & Co Portland, Maine $7.54B AUM 31.34% 1-Year Est. Return

CRM

Cardano Risk Management Rotterdam, Netherlands $13B AUM 49.44% 1-Year Est. Return

CNB

Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Ardent Capital Management's ABBV Position: Q2 2026 in Review

Ardent Capital Management held its AbbVie (ABBV) position steady in Q2 2026 at 2,530 shares worth $637K. The position accounts for 0.26% of the portfolio, ranked #28.

Ardent Capital Management first reported a position in ABBV in Q4 2021 and has held it in 18 quarters since. 921 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Ardent Capital Management held 2,530 shares of AbbVie worth $637K as of Q2 2026.
Ardent Capital Management left its AbbVie share count unchanged in Q2 2026.
AbbVie made up 0.26% of Ardent Capital Management's portfolio in Q2 2026, its #28 holding.
Ardent Capital Management first reported a position in AbbVie in Q4 2021 and has held it in 18 quarters since.
921 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Ardent Capital Management's 13F filing for Q2 2026, filed 20 Jul 2026.